Table 1.
Patient characteristics.
| All Admissions (n = 622) |
Admissions with UTI Diagnosis by the Treating Physician (n = 79) |
|
|---|---|---|
| Demographics | ||
| Age (years); (median, IQR *) | 63 (15) | 77 (16) |
| Gender (male); (n, %) | 359 (58) | 22 (28) |
| BMI ** (kg/m2); (median, IQR) | 27 (6) | 25 (7) |
| COVID-19 diagnosis (n (%)); | ||
| • PCR *** | 556 (89) | 72 (91) |
| • Clinical Diagnosis | 66 (11) | 7 (9) |
| Length of stay (median, IQR) | 7 (6) | 10 (10) |
| COVID-19 related symptoms at admission (n, %) | ||
| Cough | 363 (58) | 29 (37) |
| Fever or history of fever | 421 (68) | 52 (67) |
| Dyspnea | 358 (58) | 27 (35) |
| Thoracic pain | 142 (23) | 7 (9) |
| Laboratory findings (median, IQR; except for lymphopenia) | ||
| White blood cell count (/mm3) | 6600 (4600) | 7800 (7300) |
| Neutrophil count (/mm3) | 4845 (4188) | 5540 (5867) |
| Lymphocyte count (/mm3) | 1010 (633) | 1010 (645) |
| Ferritin (mcg/L) | 580 (869) | 465 (687) |
| CRP †(mg/dL) | 75 (127) | 72 (129) |
| Comorbidities | ||
| CCI ‡ (median, IQR) | 1 (3) | 2 (4) |
| Diabetes mellitus (n, %) | 162 (26) | 26 (33) |
| Pre-existing pulmonary disease (n, %) | 79 (13) | 13 (17) |
| Ischemic/congestive heart disease (n, %) | 72 (12) | 11 (14) |
| Other variables, possibly related to ASB ☩ or UTI § | ||
| Urinary incontinence (n, %) | 91 (15) | 36 (46) |
| Presence of a chronic urinary catheter (n, %) | 16 (3) | 6 (8) |
| Living in a nursing home (n, %) | 79 (13) | 27 (34) |
| Decreased autonomy (n, %) | 194 (31) | 54 (68) |
| Anatomical urinary tract pathology | 77 (12) | 19 (24) |
| Functional urinary tract pathology | 63 (10) | 23 (29) |
| Active neurological disease or passive with sequelae (n, %) | 87 (14) | 25 (32) |
| Cognitive disorder (n, %) | 68 (11) | 20 (25) |
| Active immune suppression (n, %) | 84 (14) | 13 (17) |
| Prognostic factors | ||
| qSOFA score at admission (median, IQR) | ||
| 0 | 303 (49) | 33 (43) |
| 1 | 272 (44) | 36 (47) |
| 2 | 28 (5) | 7 (9) |
| 3 | 2 (0) | 1 (1) |
| ICU admission (n, %) | 126 (20) | 19 (24) |
| Mechanical ventilation need (n, %) | 46 (7) | 8 (10) |
| (SpO2/FiO2 × 100) min X (median, IQR) | 296 (190) | 284 (222) |
| Mortality (n, %) | 23 (8) | 14 (18) |
* IQR: interquartile range; ** BMI: body mass index; *** PCR: polymerase chain reaction; † CRP: C-reactive protein; ☩ ASB: asymptomatic bacteriuria; § UTI: urinary tract infection; ‡ CCI: Charlson Comorbidity Index; X SpO2/FiO2 × 100 min = the lowest value of the SpO2/FiO2 rate during the total stay on a COVID-19 ward or in the ICU.